Details for New Drug Application (NDA): 207628
✉ Email this page to a colleague
NDA 207628 describes LEVALBUTEROL HYDROCHLORIDE, which is a drug marketed by Cipla, Impax Labs Inc, Luoxin Aurovitas, Mylan Speciality Lp, Norvium Bioscience, Ritedose Corp, Sun Pharm, Teva Parenteral, and Teva Pharms Usa, and is included in ten NDAs. It is available from eleven suppliers. Additional details are available on the LEVALBUTEROL HYDROCHLORIDE profile page.
The generic ingredient in LEVALBUTEROL HYDROCHLORIDE is levalbuterol hydrochloride. There are nine drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the levalbuterol hydrochloride profile page.
The generic ingredient in LEVALBUTEROL HYDROCHLORIDE is levalbuterol hydrochloride. There are nine drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the levalbuterol hydrochloride profile page.
Summary for 207628
| Tradename: | LEVALBUTEROL HYDROCHLORIDE |
| Applicant: | Luoxin Aurovitas |
| Ingredient: | levalbuterol hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 207628
| Mechanism of Action | Adrenergic beta2-Agonists |
Suppliers and Packaging for NDA: 207628
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| LEVALBUTEROL HYDROCHLORIDE | levalbuterol hydrochloride | SOLUTION;INHALATION | 207628 | ANDA | Aurobindo Pharma Limited | 65862-942 | 65862-942-03 | 30 POUCH in 1 CARTON (65862-942-03) / 1 VIAL, SINGLE-DOSE in 1 POUCH (65862-942-50) / .5 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INHALATION | Strength | EQ 0.25% BASE | ||||
| Approval Date: | Jan 31, 2017 | TE: | AN | RLD: | No | ||||
Complete Access Available with Subscription
